In stroke models, for example, perlecan acts on the α5β1 integrin receptor and VEGFR2 and PDGFRβ receptors to increase VEGF production and angiogenesis (Parham et al., 2014; Nakamura et al., 2019; Trout et al., 2020). Here, HSPG2 is linked to stroke disorder.